The International Coalition of Medicines Regulatory Authorities (ICMRA) has released comprehensive guidelines recommending how regulatory bodies can introduce aligned track and trace systems around the world to combat counterfeit or falsified products in global supply chains and markets. Published jointly by a regulators/industry working group, the ICMRA report outlines certain technical elements that if implemented would enable national and regional track and trace systems. With the ICMRA guidelines including the use of product identifiers, regulatory standards, and data and intelligence exchange, the report strongly encourages regulators to use international standards such as GS1 standards as well as standards set up by international standards body for medical products of human origin (ISBT).
Read more here.

More on: